These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 602249)
21. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans. Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226 [TBL] [Abstract][Full Text] [Related]
22. Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats. Kamimura H; Enjoji Y; Sasaki H; Kawai R; Kaniwa H; Niigata K; Kageyama S Xenobiotica; 1987 Jun; 17(6):645-58. PubMed ID: 3630201 [TBL] [Abstract][Full Text] [Related]
23. [Studies on the biotransformation of fominoben-HCl in man (author's transl)]. Zimmer A; Krüger G; Prox A; Stahl E; Wolter B; Wachsmuth H; Köster P Arzneimittelforschung; 1978; 28(4):688-92. PubMed ID: 155457 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, enterohepatic circulation and biotransformation of [2-3H]-9,9-Dimethylacridane-10-carboxylic acid S-(2-dimethylamino) thiolethyl ester in the rat and dog. Farrier DS Arzneimittelforschung; 1977; 27(3):575-83. PubMed ID: 577424 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs. Arndts D; Leb G; Förster HJ Eur J Drug Metab Pharmacokinet; 1981; 6(3):225-36. PubMed ID: 7308242 [TBL] [Abstract][Full Text] [Related]
26. Metabolic fate of the beta-blocker 14C-bupranolol in humans, dogs, and rhesus monkeys. Waller AR; Chasseaud LF; Bonn R; Taylor T; Darragh A; Girkin R; Down WH; Doyle E Drug Metab Dispos; 1982; 10(1):51-4. PubMed ID: 6124383 [TBL] [Abstract][Full Text] [Related]
27. [Biotransformation of tramadol in man and animal (author's transl)]. Lintz W; Erlaçin S; Frankus E; Uragg H Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474 [TBL] [Abstract][Full Text] [Related]
29. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Prakash C; Kamel A; Gummerus J; Wilner K Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781 [TBL] [Abstract][Full Text] [Related]
30. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733 [TBL] [Abstract][Full Text] [Related]
31. Tissue distribution and excretion in urine, feces and respiratory CO2 of [14C]-ciclosidomine in beagle dogs. Matteo MR; Zavorskas P; Esber H Arzneimittelforschung; 1985; 35(1A):329-32. PubMed ID: 3921036 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of amlodipine in the rat and the dog: a species difference. Beresford AP; Macrae PV; Stopher DA Xenobiotica; 1988 Feb; 18(2):169-82. PubMed ID: 2967592 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man. Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
35. Biotransformation of the organic nitrate trans-N-(4-nitroxycyclohexyl)acetamide in dogs. Zell C; Neidlein R; Strein K Arzneimittelforschung; 1994 Sep; 44(9):1021-8. PubMed ID: 7986238 [TBL] [Abstract][Full Text] [Related]
36. Metabolic disposition of isoxicam in man, monkey, dog, and rat. Borondy PE; Michniewicz BM Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211 [TBL] [Abstract][Full Text] [Related]
37. Metabolism and disposition of amifloxacin in laboratory animals. Johnson JA; Benziger DP Antimicrob Agents Chemother; 1985 May; 27(5):774-81. PubMed ID: 4015071 [TBL] [Abstract][Full Text] [Related]
38. Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs. Nakamura S; Ohashi M; Suzuki T; Sugawara Y; Usuki S; Takaiti O Arzneimittelforschung; 1989 Sep; 39(9):1100-8. PubMed ID: 2590259 [TBL] [Abstract][Full Text] [Related]
39. Metabolic and pharmacokinetic studies following oral administration of famciclovir to the rat and dog. Filer CW; Ramji JV; Allen GD; Brown TA; Fowles SE; Hollis FJ; Mort EE Xenobiotica; 1995 May; 25(5):477-90. PubMed ID: 7571721 [TBL] [Abstract][Full Text] [Related]
40. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone. Prakash C; Kamel A; Anderson W; Howard H Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]